A PHASE II, MULTICENTRE, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF ZD1839 (IRESSA?) IN COMBINATION WITH CASODEX? IN PATIENTS WITH OPERABLE PROSTATE CANCER
100 项与 Astrazeneca Plc /Plankstadt Plant/ 相关的临床结果
0 项与 Astrazeneca Plc /Plankstadt Plant/ 相关的专利(医药)
100 项与 Astrazeneca Plc /Plankstadt Plant/ 相关的药物交易
100 项与 Astrazeneca Plc /Plankstadt Plant/ 相关的转化医学